The startup has developed a sensory discrimination training device that utilizes two-point discrimination therapy to alleviate phantom limb pain. This self-administered device enables patients to manage their treatment independently, reducing reliance on healthcare professionals for daily supervision.
Funding
$360K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Phantom limb pain (PLP) is a chronic condition experienced by amputees, often requiring continuous management. Existing treatments may involve medication or supervised therapy sessions, potentially limiting patient independence and accessibility to care.
Solution
SensTrain offers a self-administered, at-home sensory discrimination training device designed to alleviate phantom limb pain. The device utilizes two-point discrimination therapy, targeting the neurological root cause of PLP through interactive, 30-minute daily sessions. This drug-free and non-invasive approach allows patients to manage their pain independently, reducing the need for frequent clinic visits and reliance on medication. The therapy aims to provide both immediate relief and long-term rehabilitation, with improvements typically observed within weeks of consistent use.
Target Audience
The primary target audience is individuals experiencing phantom limb pain who seek a convenient, drug-free, and self-managed therapy solution for pain relief and long-term rehabilitation.
Features
- Interactive, 30-minute daily therapy sessions.
- Two-point discrimination therapy targeting the neurological cause of PLP.
- Drug-free and non-invasive treatment.
- At-home use, eliminating the need for clinic visits.
- Personalized weekly support from trained healthcare advisors.